Abstract: Disclosed is a genetically modified oncolytic herpes simplex virus (oHISV) encoding a truncated nonsignaling variant of at least one tumor associated/specific antigen, and at least one chemokine. The expression of the truncated nonsignaling variant and the chemokine is under the control of an immediate-early gene promoter of HSV, and the truncated nonsignaling variant is expressed and presented on a tumor cell surface as a biomarker upon replication of the oHSV in the tumor cell, and the chemokine is expressed and released to induce chemotaxis of an immune cell towards the tumor cell. The genetically modified oHSV can be used in combination with CAR-T, ADC, and/or BiTE therapies.

Abstract: Hub lifting and pick-and-place equipment includes a fixed plate. The lower portion of the fixed plate is connected with a vertical plate. One side of the bottom of the vertical plate is fixedly connected with a fixed frame. The bottom of the vertical plate is hinged with a safety plate. The safety plate and the vertical plate are also connected with each other through shielding oil cylinders. A wire holder is mounted on one side of the vertical plate.

Abstract: Hub lifting and pick-and-place equipment includes a fixed plate. The lower portion of the fixed plate is connected with a vertical plate. One side of the bottom of the vertical plate is fixedly connected with a fixed frame. The bottom of the vertical plate is hinged with a safety plate. The safety plate and the vertical plate are also connected with each other through shielding oil cylinders. A wire holder is mounted on one side of the vertical plate.